WSBC

WSBC Total Costs & Expenses

$1.07BTTM · USD

Period ending:

WSBC FY Total Costs & ExpensesUSD
WSBC FY Total Costs & Expenses1987-12-31: $6.10M1988-12-31: $7.60M1989-12-31: $54.50M1990-12-31: $59.00M1991-12-31: $65.20M1992-12-31: $68.70M1993-12-31: $63.10M1994-12-31: $81.30M1995-12-31: $83.60M1996-12-31: $123.60M1997-12-31: $140.80M1998-12-31: $146.60M1999-12-31: $141.34M2000-12-31: $147.26M2001-12-31: $147.24M2002-12-31: $158.56M2003-12-31: $153.93M2004-12-31: $157.82M2005-12-31: $209.40M2006-12-31: $219.38M2007-12-31: $236.64M2008-12-31: $296.50M2009-12-31: $299.01M2010-12-31: $253.50M2011-12-31: $227.49M2012-12-31: $209.58M2013-12-31: $198.18M2014-12-31: $186.58M2015-12-31: $222.54M2016-12-31: $245.63M2017-12-31: $268.47M2018-12-31: $334.99M2019-12-31: $400.82M2020-12-31: $516.02M2021-12-31: $307.67M2022-12-31: $388.74M2023-12-31: $630.82M2024-12-31: $762.49M2025-12-31: $1.15B$1.15B$0.00
1987-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

WSBC total costs & expenses history

Total of all costs and expenses. The available annual fiscal periods series contains 39 observations from Dec 31, 1987 to Dec 31, 2025.

Wesbanco Inc Total Costs & Expenses — Annual fiscal periods (USD)
Period endingTotal Costs & Expenses (USD)
1,152,490,000
762,491,000
630,823,000
388,743,000
307,665,000
516,018,000
400,824,000
334,991,000
268,465,000
245,628,000
222,538,000
186,579,000
198,177,000
209,581,000
227,487,000
253,497,000
299,012,000
296,502,000
236,642,000
219,379,000
209,399,000
157,819,000
153,934,000
158,561,000
147,243,000
147,260,000
141,339,000
146,600,000
140,800,000
123,600,000
83,600,000
81,300,000
63,100,000
68,700,000
65,200,000
59,000,000
54,500,000
7,600,000
6,100,000

Compare total costs & expenses

All WSBC financial metrics · WSBC stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.